Litigation Details for Silvergate Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2019)
✉ Email this page to a colleague
Silvergate Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2019)
| Docket | ⤷ Subscribe | Date Filed | 2019-04-11 |
| Court | District Court, D. Delaware | Date Terminated | 2021-06-29 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Patents | 10,039,745; 10,154,987; 6,211,244; 6,316,460; 9,375,405; 9,669,008; 9,808,442 | ||
| Attorneys | Wendy L. Devine | ||
| Firms | Young, Conaway, Stargatt & Taylor LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Silvergate Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC
The small molecule drugs covered by the patents cited in this case are ⤷ Subscribe , ⤷ Subscribe , and ⤷ Subscribe .
Biologic Drugs cited in Silvergate Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC
The biologic drug covered by the patents cited in this case is ⤷ Subscribe .
Details for Silvergate Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2020-07-22 | 109 | Notice of Service | Buckton on Infringement of U.S. Patent 9,669,008; 9,808,442; 10,039,745; and 10,154,987; and (2) Opening…John D. Mahan, Jr., M.D. on Infringement of U.S. Patent 9,808,442 and 10,154,987 filed by Silvergate Pharmaceuticals… 11 April 2019 1:19-cv-00678 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2020-08-21 | 111 | Notice of Service | Graham Buckton on Validity of U.S. Patent 9,669,008; 9,808,442; 10,039,745; and 10,154,987; (2) Expert Report… 11 April 2019 1:19-cv-00678 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
